Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (211-220 of 243) with videos related to

Pageof 25
Sort By:
Annals of Surgical Oncology|March 29, 2022
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
Histopathology|January 27, 2015
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologistsDaniel M Berney, Ferran Algaba, Mahul Amin, et al.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
Cell Reports. Medicine|November 15, 2023
Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomasXiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, et al.
Cancers|February 2, 2021
The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall SurvivalElise F Nassif, Bernhard Mlecnik, Constance Thibault, et al.
European Urology Focus|August 29, 2021
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
Scientific Reports|January 22, 2020
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic driversGabriel G Malouf, Ronan Flippot, Yiyu Dong, et al.
Cancer Letters|January 15, 2026
ABCG2-Mediated SN-38 Efflux Drives Resistance to Sacituzumab Govitecan in Urothelial CarcinomaIsabella Prantl, Reinhard Grausenburger, Julia Müller, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancerSatoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.
European Urology Open Science|May 9, 2022
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter StudyNico C Grossmann, Pawel Rajwa, Fahad Quhal, et al.
Pageof 25

Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Annals of Surgical Oncology|March 29, 2022
Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
Histopathology|January 27, 2015
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologistsDaniel M Berney, Ferran Algaba, Mahul Amin, et al.
Molecular Carcinogenesis|September 29, 2021
Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladderEkaterina Laukhtina, Victor M Schuettfort, David D'Andrea, et al.
Cell Reports. Medicine|November 15, 2023
Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomasXiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, et al.
Cancers|February 2, 2021
The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall SurvivalElise F Nassif, Bernhard Mlecnik, Constance Thibault, et al.
European Urology Focus|August 29, 2021
The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical CystectomyKeiichiro Mori, Victor M Schuettfort, Satoshi Katayama, et al.
Scientific Reports|January 22, 2020
Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic driversGabriel G Malouf, Ronan Flippot, Yiyu Dong, et al.
Cancer Letters|January 15, 2026
ABCG2-Mediated SN-38 Efflux Drives Resistance to Sacituzumab Govitecan in Urothelial CarcinomaIsabella Prantl, Reinhard Grausenburger, Julia Müller, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancerSatoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.
European Urology Open Science|May 9, 2022
Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter StudyNico C Grossmann, Pawel Rajwa, Fahad Quhal, et al.
Pageof 25